Your Cart

Appendix 3X — Initial Director's Interest Notice

Appendix 3X — Initial Director's Interest Notice

Imagion Biosystems Limited has lodged Appendix 3X, Initial Director’s Interest Notice, with the Australian Securities Exchange.
View the Initial Director’s Interest Notice.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.